Orit Picard
Impact in
- Genetics top 1%
- Inflammatory Bowel Disease
- Immunology top 2%
- Biosimilars and Bioanalytical Methods
- Immunodeficiency and Autoimmune Disorders
Papers in
- Genetics 35
- Inflammatory Bowel Disease 35
- Immunology 33
- Immunodeficiency and Autoimmune Disorders 18
- T-cell and B-cell Immunology 4
- Immune Cell Function and Interaction 4
- Co-authors
- Ella Fudim (46 shared papers)Shomron Ben‐Horin (50 shared papers)Yehuda Chowers (28 shared papers)Miri Yavzori (46 shared papers)Uri Kopylov (38 shared papers)Rami Eliakim (29 shared papers)Bella Ungar (26 shared papers)D. Coscas (6 shared papers)
In The Last Decade
Orit Picard
64 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 102
- Genetics 1.5k
- Immunology 1.1k
- Epidemiology 1.1k
- Gastroenterology 135
- Rheumatology 187
Countries citing papers authored by Orit Picard
This map shows the geographic impact of Orit Picard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orit Picard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orit Picard more than expected).
Fields of papers citing papers by Orit Picard
This network shows the impact of papers produced by Orit Picard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orit Picard. The network helps show where Orit Picard may publish in the future.
Co-authors
The 25 scholars most cited alongside Orit Picard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 276 | |
| 2 | 2013 | 241 | |
| 3 | 2012 | 237 | |
| 4 | 2010 | 176 | |
| 5 | 2015 | 136 | |
| 6 | 2017 | 95 | |
| 7 | 2016 | 88 | |
| 8 | 2011 | 83 | |
| 9 | 2011 | 74 | |
| 10 | 2017 | 67 | |
| 11 | 2016 | 62 | |
| 12 | 2019 | 53 | |
| 13 | 2008 | 48 | |
| 14 | 2012 | 47 | |
| 15 | 2008 | 45 | |
| 16 | 2019 | 44 | |
| 17 | 1996 | 44 | |
| 18 | 1982 | 43 | |
| 19 | 2009 | 34 | |
| 20 | 2017 | 27 |
About Orit Picard
Orit Picard is a scholar working on Genetics, Immunology, Epidemiology, Surgery and Oncology, having authored 67 papers that have together received 2.3k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (35 papers), Immunodeficiency and Autoimmune Disorders (18 papers), Microscopic Colitis (17 papers), Helicobacter pylori-related gastroenterology studies (5 papers), T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (4 papers), Celiac Disease Research and Management (4 papers) and Pregnancy and Medication Impact (4 papers). The work is most often cited by research in Genetics (1.5k citations), Immunology (1.1k citations), Epidemiology (1.1k citations), Gastroenterology (135 citations) and Rheumatology (187 citations). Orit Picard has collaborated with scholars based in Israel, France and China. Frequent co-authors include Ella Fudim, Shomron Ben‐Horin, Yehuda Chowers, Miri Yavzori, Uri Kopylov, Rami Eliakim, Bella Ungar, D. Coscas, Batia Weiss and Matti Waterman. Their work appears in journals such as Journal of Crohn s and Colitis, Gut, Alimentary Pharmacology & Therapeutics, Clinical Gastroenterology and Hepatology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.